Bedrijfsvoering Merck & Co., Inc.

MRK

US58933Y1055

Farmaceutische producten

Beurs gesloten - Nyse Andere beurzen 22:00:02 02-12-2024			Nabeurs 00:11:08
100,61 ^USD	-1,01%		100,90	+0,29%

02/12	MERCK & CO., INC. : Bernstein is Neutraal over het aandeel	ZM
29/11	Enhertu, Orpathys van Astrazeneca behoren tot de 91 geneesmiddelen die zijn toegevoegd aan de nationale lijst van geneesmiddelen voor vergoeding in China	MT

Uitvoerend comité: Merck & Co., Inc.

Bedrijfsleider

Beklede functiesVan

Robert Davis

57 jaar

Chief Executive Officer	01-07-2021
President	01-04-2021

Kelly E. W. Grez

Corporate Secretary

Sylvia A. Ayler

General Counsel

01-01-2021

Dalton Smart

58 jaar

Comptroller/Controller/Auditor

04-12-2023

Caroline Litchfield

55 jaar

Director of Finance/CFO

01-04-2021

Dave Williams

55 jaar

Chief Tech/Sci/R&D Officer

01-08-2020

Chirfi Guindo

58 jaar

Sales & Marketing

01-07-2022

Jennifer Zachary

46 jaar

General Counsel

01-04-2018

Peter Dannenbaum

Investor Relations Contact

01-07-2017

Betty Larson

48 jaar

Human Resources Officer

01-04-2024

Samenstelling van de raad van bestuur: Merck & Co., Inc.

Directeur

RadenVan

Robert Davis

57 jaar

Governance Committee	08-01-2018
Finance Committee Chair	08-01-2018

Patricia Russo

71 jaar

Finance Committee	09-06-2011
Executive Committee	24-07-2009
Compensation Committee	02-11-2015
Governance Committee Chair	09-06-2011
Governance Committee	02-11-2015
Compensation Committee Chair
Audit Committee	15-06-2023
HR Committee	02-11-2015
Nominating Committee	02-11-2015

Douglas Baker

65 jaar

Compensation Committee	24-03-2015
HR Committee	13-03-2013
Governance Committee Chair	13-03-2013
Audit Committee	24-05-2022
Governance Committee	24-05-2022

Tom Glocer

64 jaar

Compensation Committee	01-05-2015
Governance Committee Chair
Governance Committee	01-01-2021
Nominating Committee	01-01-2021
Audit Committee	01-05-2015

Risa Lavizzo-Mourey

69 jaar

Compensation Committee	26-05-2020
Governance Committee Chair	03-01-2023
Nominating Committee Chair	03-01-2023
Compensation Committee Chair	20-04-2021

Pamela Craig

67 jaar

Governance Committee	01-09-2015
Audit Committee Chair	01-09-2015
Compensation Committee	01-01-2018
Audit Committee	29-06-2021

Inge Thulin

70 jaar

Executive Committee	02-06-2011
Compensation Committee	01-03-2018
Governance Committee	01-03-2018

Kathy Warden

52 jaar

Audit Committee	16-03-2020
Governance Committee	22-03-2022

Christine Seidman

71 jaar

Audit Committee

16-03-2020

Mary Coe

57 jaar

Compensation Committee

Paul Rothman

65 jaar

Audit Committee

01-09-2015

Stephen Mayo

62 jaar

Audit Committee

16-11-2021

Recente benoemingen: Merck & Co., Inc.

Merck benoemt Surendralal L. Karsanbha tot lid van de Raad van Bestuur, met ingang van 1 januari 2025	22/11	CI
Zentalis Pharmaceuticals benoemt Julie Eastland tot CEO	13/11	MT
Good Energy zegt dat ZapMap uitbreidt naar het Europese vasteland	13/12	AN
Merck & Co, Inc. kondigt wijzigingen in het management aan, met ingang van 4 december 2023	28/11	CI
Topverhalen op de middag: Yellow geeft op; JNJ-afdeling verliest tweede bod op faillissement; JB Hunt koopt Nikola Trucks, Walmart verhoogt Flipkart-belang	31-07-23	MT
De CEO van Merck & Co. neemt in december de voorzittersrol over	27-10-22	MT
Merck kondigt bestuurswijzigingen aan	26-10-22	CI

Meer nieuws

Voormalige zaakvoerders en bestuurders: Merck & Co., Inc.

Insider

Beklede functies

VanTot

James Christopher Scalet

Chief Tech/Sci/R&D Officer

03-11-2009

Samuel O. Thier

Director/Board Member

01-01-1994

03-11-2009

Dennis Erb

Corporate Officer/Principal

04-11-2009

Christopher Garland

Public Communications Contact

04-11-2009

Graeme Bell

Public Communications Contact

04-01-2007

04-11-2009

Stefan Oschmann

Corporate Officer/Principal

01-10-2005

04-11-2009

Steven Kelmar

Public Communications Contact

01-08-2006

04-11-2009

Margaret McGlynn

Corporate Officer/Principal

01-01-2006

01-11-2009

Johnnetta Betsch Cole

Director/Board Member

01-01-1994

01-03-2009

Wendy Yarno

Human Resources Officer	-	-
Sales & Marketing	01-12-1999	01-09-2008

David Anstice

Corporate Officer/Principal	01-01-2003	01-08-2008
President	01-01-2003	01-01-2006

Richard Henriques

Comptroller/Controller/Auditor	01-01-1981	01-01-2008
Corporate Officer/Principal	01-01-1981	01-01-2008

Judy Lewent

Director of Finance/CFO

01-01-1990

01-09-2007

Peter D. Löscher

Corporate Officer/Principal

01-05-2006

31-05-2007

William G. Bowen

Director/Board Member

01-01-1986

24-04-2007

Marcia Avedon

Human Resources Officer

01-01-2002

01-12-2006

Per Wold-Olsen

Corporate Officer/Principal

01-01-1974

01-10-2006

Penny M. Heaton

Chief Tech/Sci/R&D Officer

01-01-1999

01-09-2006

Joan Wainwright

Public Communications Contact

01-06-2000

01-06-2006

Larry Bossidy

Director/Board Member

01-01-1992

01-04-2006

Howard Chin

Corporate Officer/Principal

01-01-2004

31-12-2005

Michael R. Goldberg

Corporate Officer/Principal

01-01-1988

01-01-2005

Heidi Miller

Director/Board Member

01-01-2000

15-12-2004

William Daley

Director/Board Member

01-01-2000

01-01-2004

Wendy Perrow

Corporate Officer/Principal

01-01-1989

Ben Shapiro

Corporate Officer/Principal

01-09-1990

01-07-2003

Paul Howes

Corporate Officer/Principal

01-01-1998

01-06-2003

Patrick Yang

Corporate Officer/Principal

01-01-1992

01-01-2003

Linda Burns

Human Resources Officer

01-01-2002

01-01-2003

Wendy Dixon

Sales & Marketing

01-01-1996

01-11-2001

J. Carroll

Sales & Marketing

01-01-1976

01-01-2001

Beth Seidenberg

Private Equity Investor

01-07-1998

31-03-2000

Thomas A. Reed

Corporate Officer/Principal

01-09-1999

01-03-2000

Albert I. Wertheimer

Corporate Officer/Principal

01-01-1997

01-01-2000

Anne Tatlock

Director/Board Member	03-11-2009	-
Independent Dir/Board Member	04-05-2011	-

Elizabeth Hamilton Seabury Wyatt

Corporate Officer/Principal

01-01-1980

01-01-2000

Kamil Ali-Jackson

General Counsel

01-02-1990

01-07-1998

N. Coles

Corporate Officer/Principal

01-01-1992

01-01-1996

C. Boyd Clarke

Corporate Officer/Principal

01-01-1977

01-01-1996

Michael Tarnow

President

01-01-1973

Stewart John Hen

Corporate Officer/Principal

01-01-1990

Jerome C. Keller

Sales & Marketing

01-01-1986

01-01-1993

Richard Markham

Chief Operating Officer	01-01-1973	01-01-1993
President	01-01-1973	01-01-1993

Douglas J. MacMaster

Corporate Officer/Principal

01-01-1961

01-01-1992

Abraham E. Cohen

Corporate Officer/Principal

01-01-1982

01-01-1992

Julian Adams

Corporate Officer/Principal

01-01-1982

31-12-1987

Kenneth R. Nover

Corporate Officer/Principal

01-01-1974

01-01-1987

Kevin P. Brady

Comptroller/Controller/Auditor

01-01-1980

Teresa Leezer

Corporate Officer/Principal

David Popler

Corporate Officer/Principal

Michael N. Sohn

Corporate Officer/Principal

Daisy Fernandez Seebach

Corporate Officer/Principal

Robert Alonso

Corporate Officer/Principal

Maurisa Sommerfield

Chief Tech/Sci/R&D Officer	-	03-05-2011
Corporate Officer/Principal	03-05-2011	-

Al Cini

Corporate Officer/Principal

Frank Adell

Corporate Officer/Principal

David Osborne

Corporate Officer/Principal

Donald S. Parker

Corporate Officer/Principal

Rick Goulburn

Corporate Officer/Principal

Robert O. Likoff

Corporate Officer/Principal

Samantha Weber

Corporate Officer/Principal

Christopher Anderson

Corporate Officer/Principal

Arthur J. Hiller

Corporate Officer/Principal

Howard F. Solomon

Corporate Officer/Principal

Mark Penn

Corporate Officer/Principal

Steven B. Bernitz

Corporate Officer/Principal

Valentin A. Adia

Corporate Officer/Principal

Viren Mehta

Corporate Officer/Principal

Jack Khattar

Corporate Officer/Principal

Michael Derby

Corporate Officer/Principal

Cecil B. Pickett

Corporate Officer/Principal

Michele Washko

Corporate Officer/Principal

Todd F. Kirschner

Corporate Officer/Principal

Liping Fan

Corporate Officer/Principal

Zev S. Scherl

Corporate Officer/Principal

Tim Biro

Chief Operating Officer	-	-
Corporate Officer/Principal	-	26-07-2011

Ting Oei

Corporate Officer/Principal

Scott Schandler

Corporate Officer/Principal

Thomas Salzmann

Corporate Officer/Principal

David T. Molowa

Corporate Officer/Principal

Edward Rhoads

Sales & Marketing

P. Reed Maurer

Corporate Officer/Principal

Debra A. Bollwage

Corporate Secretary

Derek Hodkey

Chief Tech/Sci/R&D Officer

Jon Scanlon

Corporate Officer/Principal

Anne Clothier

Corporate Officer/Principal

Kris Venkat

Corporate Officer/Principal

Michael Giuliani

Corporate Officer/Principal

William Polvino

Corporate Officer/Principal

Anton Clarke Atwell

Corporate Officer/Principal

Timothy Noyes

Corporate Officer/Principal

Rohini Hira

Corporate Officer/Principal

Letty Z. Zemaitis

Corporate Officer/Principal

Leeftijdsdistributie van bedrijfsleiders

Ratio vrouwen/mannen

Man	25
Vrouw	16

Waarvan leden van het uitvoerend comité

Man	5
Vrouw	5

Waarvan bestuurders

Man	8
Vrouw	4

ESG Refinitiv

B-

Milieu

Emissies

Innovatie

Gebruik van middelen

Bedrijfsvoering

MVO-strategie

Beheer

Aandeelhouders

Controverse

Merck & Co., Inc. is gespecialiseerd in de ontwikkeling, de vervaardiging en de verkoop van therapeutische producten en vaccins die op recept verkocht worden. De omzet per activiteit is als volgt onderverdeeld: - verkoop van farmaceutische producten (67%): bestemd voor de behandeling van hoge bloeddruk, osteoporose, atherosclerose, ademhalingsaandoeningen, bacteriële en schimmelziekten, oogaandoeningen en urologische ziekten, acute migraine, haaruitval bij mannen, enz.; - verkoop van vaccins (22,1%); - verkoop van producten voor diergezondheid (9,4%); - andere (1,5%). De geografische verdeling van de omzet is als volgt: Verenigde Staten (47,4%), Europa-Midden-Oosten-Afrika (22%), China (11,3%), Japan (5,3%), Azië-Stille Oceaan (5,4%), Latijns-Amerika (5,1%) en andere (3,5%).

Werknemers

71.000

Sector

Farmaceutische producten

Agenda

19:20 - Evercore ISI HealthCONx Conference

Meer informatie over het bedrijf